Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of DaxibotulinumtoxinA for Injection for the Treatment of Adult Upper Limb Spasticity

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* 18 to 75 years of age~* Written informed consent including authorization to release health information~* Focal upper limb spasticity (ULS) after a stroke (as defined by WHO criteria) or traumatic brain injury (TBI), last stroke or TBI \> 24 weeks prior to Screening~* ULS with the primary aggregate posture~* Moderate to severe ULS with a MAS score ≥ 2 at the elbow, wrist, and finger flexors~* Moderate to severe functional disability (Disability Assessment Score \[DAS\] score ≥2) on the principal target of treatment~* Has sufficient cognitive and communication ability to be able to give informed consent~Exclusion Criteria:~* Upper limb spasticity attributable to an etiology other than stroke or TBI.~* Bilateral upper limb paresis or quadriplegia.~* Initiated in physiotherapy of the upper extremities ≤ 30 days prior to Screening or planned to start physiotherapy of the upper extremities during the course of the study.~* Previous or planned treatment of the spastic upper limb with phenol, alcohol injection, or surgery~* Profound muscular atrophy or fixed contracture leading to marked limitation on range of motion~* Prior treatment with intrathecal baclofen~* Any neuromuscular neurologic conditions (amyotrophic lateral sclerosis, Lambert- Eaton, myasthenia gravis)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- DAXI 250 U (Type: EXPERIMENTAL): DAXI for injection for the treatment of Upper Limb Spasticity (ULS) in Adults with 250 U dose
- DAXI 375 U (Type: EXPERIMENTAL): DAXI for injection for the treatment of Upper Limb Spasticity (ULS) in Adults with 375 U
- DAXI 500 U (Type: EXPERIMENTAL): DAXI for injection for the treatment of Upper Limb Spasticity (ULS) in Adults with 500 U
- Placebo (Type: PLACEBO_COMPARATOR): Placebo group

Based on this trial design, predict the completion outcome and termination type (if applicable).